A screening procedure for primary aldosteronism based on the diasorin liaison® automated chemiluminescent immunoassay for direct renin

Annals of Clinical Biochemistry

Volumn 47, Issue 3, 2010, Pages 195-199

  Dorrian, C A ^a   Toole, B J ^a   Alvarez Madrazo, S ^b   Kelly, A ^a   Connell, J M C ^b   Wallace, A M ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; PRORENIN; RENIN;

ADULT; AGED; ARTICLE; AUTOMATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; INTERMETHOD COMPARISON; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REFERENCE VALUE; SCREENING; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ALDOSTERONE; CHEMILUMINESCENT MEASUREMENTS; HUMANS; HYPERALDOSTERONISM; IMMUNOASSAY; MIDDLE AGED; RENIN; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 77951820593     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.009230     Document Type: Article

References (11)

1. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:3266-3281
2. de Bruin RA, Bouhuizen A, Diederich S, Perschel FH, Boomsma F, Deinum J. Validation of a new automated renin assay. Clin Chem 2004;50:2111-2116 (Pubitemid 39425849)
3. Perschel FH, Schemer R, Seiler L, et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem 2004;50:1650-1655 (Pubitemid 39121234)
4. Derkx FH, Tan-Tjiong L, Wenting GJ, Boomsma F, Man in 't Veld AJ, Schalekamp MA. Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. Hypertension 1983;5:244-256
5. Freel EM, Ingram M, Friel EC, et al. Phenotypic consequences of variation across the aldosterone synthase and 11-beta hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT Study. Clin Endocrinol 2007;67:832-838 (Pubitemid 350135124)
6. Montori VM, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc 2001;76:877-882 (Pubitemid 32825908)
7. Campbell DJ, Nussberger J, Stowasser M, et al. Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 2009;55:867-877
8. Krop M, Garrelds IM, de Bruin RJ, et al. Aliskiren accumulates in renin secretory granules and binds plasma prorenin. Hypertension 2008;52:1076-1083
9. Derkx FHM, Schalenkamp MADH. Human prorenin: pathophysiology and clinical implications. Clin Exp Hypertens 1988;A10:1213-1225
10. Alvarez-Madrazo S, Padmanabhan S, Mayosi BM, et al. Familial and phenotypic associations of the aldosterone renin ratio. J Clin Endocrinol Metab 2009;94:4324-4333
11. Meneton P, Galan P, Bertrais S, Heudes D, Hercberg S, Ménard J. High plasma aldosterone and low renin predict blood pressure increase and hypertension in middle-aged Caucasian populations. J Hum Hypertens 2008;22:550-558